Publication:4894950
From MaRDI portal
zbMath0870.92006MaRDI QIDQ4894950
Publication date: 8 October 1996
49N70: Differential games and control
92C50: Medical applications (general)
49N75: Pursuit and evasion games
92-01: Introductory exposition (textbooks, tutorial papers, etc.) pertaining to biology
92-02: Research exposition (monographs, survey articles) pertaining to biology
Related Items
Dynamic optimization of dual-mode hybrid systems with state-dependent switching conditions, Optimal control for a mathematical model for chemotherapy with pharmacometrics, The Structure of Optimal Protocols for a Mathematical Model of Chemotherapy with Antiangiogenic Effects, Control variable parameterisation with penalty approach for hypersonic vehicle reentry optimisation, Constrained bilinear control problem: Application to a cancer chemotherapy model, Mathematical modeling and optimal control problems in brain tumor targeted drug delivery strategies, Unnamed Item, Simple ODE models of tumor growth and anti-angiogenic or radiation treatment, Recovery of normal hemopoiesis in disseminated cancer therapy -- a model, Dynamic response of cancer under the influence of immunological activity and therapy, A cellular automata model of chemotherapy effects on tumour growth: targeting cancer and immune cells, Sparse control for continuous‐time systems, Combination of antiangiogenic treatment with chemotherapy as a multi‐input optimal control problem, Generating locally optimal trajectories for an automatically driven car, A survey of optimization models on cancer chemotherapy treatment planning, Catalog of the optimal controls in cancer chemotherapy for the Gompertz model depending on PK/PD and the integral constraint, Optimal control problems with incomplete and different integral time domains in the objective and constraints, An optimal machine maintenance problem with probabilistic state constraints, Modeling and control of pharmacodynamics, Optimisation modelling of cancer growth, Optimal control problems arising in the zinc sulphate electrolyte purification process, Visual MISER: an efficient user-friendly visual program for solving optimal control problems, Multi-modal control using adaptive motion description languages, Application of optimal control theory to analysis of cancer chemotherapy regimens, Evaluating the efficacies of maximum tolerated dose and metronomic chemotherapies: a mathematical approach, Mixed immunotherapy and chemotherapy of tumors: feedback design and model updating schemes, Time-optimal hands-off control for linear time-invariant systems, Dynamical behaviour of a tumor-immune system with chemotherapy and optimal control, On the role of the objective in the optimization of compartmental models for biomedical therapies, Optimal control of cancer chemotherapy with delays and state constraints, Numerical optimal control of a size-structured PDE model for metastatic cancer treatment, Robust optimization for a nonlinear switched time-delay system with noisy output measurements using hybrid optimization algorithm, A 3-compartment model for chemotherapy of heterogeneous tumor populations, Optimal control oriented to therapy for a free-boundary tumor growth model, Optimization of virotherapy for cancer, Optimal chemotherapy schedules from tumor entropy, Optimal control of treatment in a mathematical model of chronic myelogenous leukemia, Control parameterization enhancing transform for optimal control of switched systems, Optimal control problems with multiple characteristic time points in the objective and constraints, Genetic algorithms for modelling and optimisation, Optimal control problems for differential equations applied to tumor growth: state of the art, Control parameterization approach to time-delay optimal control problems: a survey, Competition between populations: preventing domination of resistant population using optimal control, OPTIMAL CONTROL OF MULTIPLE-TIME DELAYED SYSTEMS BASED ON THE CONTROL PARAMETERIZATION METHOD, Mixed-Effects State-Space Models for Analysis of Longitudinal Dynamic Systems, ON OPTIMAL CHEMOTHERAPY FOR HETEROGENEOUS TUMORS